MedTrace Logo

Application of CTA-based Radiomic Phenotyping of PCAT and Fluid Dynamics in Atherosclerotic Disease (APPLE)

NCT06498830 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-07-12

No results posted yet for this study

Summary

This study (APPLE study) intends to retrospectively enroll more than 2000 patients who who underwent ≥2 coronary computed tomography angiography (CCTA) with ≥3 months interval from 11 hospitals in more than 4 provinces in China.

Conditions

  • Computed Tomography Angiography
  • Inflammation of Adipose Tissue
  • CFD

Sponsors & Collaborators

  • Jinling Hospital, China

    lead OTHER

Principal Investigators

  • Longjiang Zhang, MD · Jinling Hospital, Medical School of Nanjing University, Nanjing, China

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-17
Primary Completion
2024-07-01
Completion
2024-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06498830 on ClinicalTrials.gov